You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Bimatoprost in the Treatment of Hypotrichosis

Bratton, Emily M.; Davies, Brett W.; Hink, Eric M.; Durairaj, Vikram D.

Journal of the Dermatology Nurses' Association:
doi: 10.1097/JDN.0b013e3182a52462
Feature Articles
Abstract

ABSTRACT: Hypotrichosis plays a role in the perception of beauty and attractiveness for many patients. Bimatoprost ophthalmic solution (0.03%; Latisse, Allergan, Inc., Irvine, CA) aids in the treatment of hypotrichosis and offers a safe and effective method of achieving fuller, darker, and longer eyelashes, creating an aesthetically pleasing outcome. Nursing staff must obtain a comprehensive basis of knowledge with regard to the pharmacology, accurate application, and side effects of the drug in order to counsel patients on appropriate use and expected outcome.

Author Information

Emily M. Bratton, MD, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

Brett W. Davies, MD, MS, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

Eric M. Hink, MD, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

Vikram D. Durairaj, MD, FACS, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

The authors declare no conflicts of interest.

Correspondence concerning this article should be addressed to Vikram D. Durairaj, MD, FACS, University of Colorado Hospital, 12605 E. 16th Ave., Aurora, CO 80045. E-mail: Vikram.Durairaj@ucdenver.edu.

Copyright © 2013 by the Dermatology Nurses' Association.